HCA Healthcare's share price up after it beats Q1 expectations

"The results for the quarter were driven by strong revenue growth and improvements in operating margin," said HCA CEO Samuel Hazen in a call with analysts on the health system's first-quarter earnings this week. (HCA Healthcare)

Wall Street responded favorably to the latest earnings report from HCA Healthcare even as the health system giant reported a slight dip in profits in the first quarter. 

HCA Healthcare reported net income of about $1 billion, or $2.97 per diluted share, in the first quarter, down from $1.1 billion, or $3.18 per diluted share, in the first quarter of 2018.  During that time, it also reported its revenues jumped nearly 10% to $12.5 billion in the first quarter, compared to $11.4 billion in the first quarter of 2018.

The company's share price rose about 2% on Tuesday after the earnings report.

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

"The results for the quarter were driven by strong revenue growth and improvements in operating margin," said HCA CEO Samuel Hazen in a call with analysts. "Revenue grew by almost $1.1 billion, close to 10% in the quarter. This growth was driven by volume growth in commercial business, volume growth in more complex services and new acquisitions."

RELATED: HCA's incoming CEO offers his take on the future of the health giant as income jumps in third quarter

But for funding employee retirement matching—an expense to the tune of $428 million—year-over-year comparisons would have been much more favorable, officials said.

HCA increased its 2019 guidance with adjusted EBITDA expected to range between $9.45 billion and $9.85 billion and earnings per share expected to range between $9.80 and $10.40 per diluted share. HCA also declared a quarterly cash dividend of $0.40 per share on the company’s common stock. 

Suggested Articles

As drugmakers face billions in legal settlements and judgments, we must keep our eye on what will truly defeat the opioid crisis.

As the public debate on health reform rolls on, a new report analyzes how these different approaches could impact insurers' bottom lines.

A House panel is going to consider several changes to Nancy Pelosi's drug prices plan, including stiff penalties for not being transparent.